Raising Health

Vijay Pande and Julie Yoo from a16z Bio + Health discuss grand challenges in healthcare AI, including AI integration in healthcare workflows, value-based care, and innovation in clinical trials. They also share their thoughts on the AI startups they hope to see in the industry.

Greg Meyers, EVP and Chief Digital and Technology Officer at Bristol Myers Squibb, discusses AI's impact on drug discovery with a16z Bio + Health partner Jorge Conde. They explore AI integration strategies, emerging modalities, and tips for startups partnering with biopharma firms.

Guests Julie Yoo and Jay Rughani from a16z Bio + Health discuss AI adoption in healthcare with executives, covering topics like improving efficiency, patient messaging, measuring tech ROI, navigating adoption challenges, and building strategic partnerships.

Exploring the biotech revolution with Vijay Pande, discussing AI impact on drug development, challenges in biotech startups, healthcare transformation through software engineering, navigating regulatory landscapes, and the evolution of healthcare towards value-based care.

Discover the hidden secrets of LINE-1 in our genome, once dismissed as junk DNA but now linked to autoimmunity, cancer, neurodegeneration, and aging. Rome Therapeutics is paving the way to target LINE-1 and other 'dark genome' factors for disease treatment, showcasing promising advancements in drug development.

Vijay Pande and Steph Smith discuss using DNA as data storage, comparing it to Moore's Law. They explore DNA's capacity, longevity, and potential for the future of biotech. The podcast covers advancements in DNA storage, challenges in DNA synthesis, and the efficiency of using DNA for data storage.

Join Julie Klapstein and Julie Yoo as they discuss the evolution of healthcare technology, challenges faced by providers and payers, and the role of AI in improving revenue cycle management and clinical decision support. Explore Julie Klapstein's journey in healthcare IT, from battling outdated systems to embracing network effects. Discover the potential of AI in automating tasks within EMR systems and enhancing efficiency in the healthcare industry.

Ben Oakes, Scribe Therapeutics cofounder and CEO, discusses his journey in genome editing, transforming bacterial immune systems into genome editing tools. They explore the challenges of engineering these molecules and the potential for life-changing therapeutics. Topics include the intersection of engineering and biology, advancements in gene editing for chronic conditions, and the role of luck in discoveries.

Josh Clemente, cofounder and president of Levels, discusses wearable tech for tracking biomarkers and the potential of AI in simplifying wearables data into actionable health profiles. He shares his journey from SpaceX to cofounding Levels and talks about the future of continuous health awareness. The podcast also explores the significance of continuous glucose monitoring, the limitations of glucose detecting sensors, and the potential applications of wearable device data in healthcare.

Former gymnast Aly Raisman discusses her transition to being an investor, her passion for financial literacy, and her appreciation for founders' work ethic. They also talk about mental health during their gymnastics career, the importance of therapy and nutrition, and the challenges in the healthcare system.